“…CCR4 [407], CCR2 [408], CD48 [409], CD28 [410], CCL3 [411], CTLA4 [412], C6 [413], MICB (MHC class I polypeptide-related sequence B) [414], DRD3 [415], HGF (hepatocyte growth factor) [416], DIO3 [417], TTR (transthyretin) [418], GRHL3 [419], VEGFA (vascular endothelial growth factor A) [420], ADM (adrenomedullin) [421], CHI3L1 [422], SOX3 [423], MAG (myelin associated glycoprotein) [424], CNP (2’,3’-cyclic nucleotide 3’ phosphodiesterase) [425], SREBF1 [426], OLIG2 [427], ATF3 [428], NGFR (nerve growth factor receptor) [429], TF (transferrin) [430], GLUL (glutamate-ammonia ligase) [324]. MOG (myelin oligodendrocyte glycoprotein) [431], ERBB3 [432], NHLH2 [433], GADD45B [434], PADI2 [435], ADORA1 [436], NINJ2 [437], WNT7A [438], DAO (D-amino acid oxidase) [439], PRODH (proline dehydrogenase 1) [440] and HCRTR1 [441] could regulate the development of psychiatric disorders. CCR2 [442], FASLG (Fas ligand) [443], GPNMB (glycoprotein nmb) [444], NPY2R [445], TRPM8 [446], TTR (transthyretin) [447], ADM (adrenomedullin) [448], CHI3L1 [375], CDH1 [377], HIP1R [449], SEMA4D [450], HAPLN2 [451], MYRF (myelin regulatory factor) [452], BIN1 [453], BMP2 [454], APLP1 [391], SEPTIN4 [455], DAO (D-amino acid oxidase) [456], TKTL1 [347], ADAP1 [457], HPDL (4-hydroxyphenylpyruvate dioxygenase like) [458], NME3 [459], SPON1 [460] and LGALS3BP [225] were revealed to be altered expressed in neurodegenerative diseases.…”